trending Market Intelligence /marketintelligence/en/news-insights/trending/rCJv48839SluQ_-KPvmBAg2 content esgSubNav
In This List

Report: Sucampo Pharmaceuticals explores options, potential sale

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Report: Sucampo Pharmaceuticals explores options, potential sale

Sucampo Pharmaceuticals Inc. is assessing options — including putting the company up for sale — after it received takeover interest, Bloomberg News reported, citing people familiar with the matter.

Sucampo has not yet decided what it will do and may opt to seek growth through acquisitions instead, the sources noted.

The U.S. biopharmaceutical company could be attractive for large drugmakers interested in gastroenterology, which is Sucampo's focus, the insiders added.